Nexstim announces navigated brain therapy system, the first personalized magnetic stimulation solution with CE mark for treatment of depression and stroke rehabilitation
Helsinki, Finland: 10 December 2012 - Nexstim Oy, a medical device company, announced today that the Navigated Brain Therapy (NBT) System meets the requirements of the European Medical Devices Directive (MDD).The NBT System is the first non-invasive, non-systemic therapeutic device CE-marked to offer patients a personalized treatment for major depression. In addition, the NBT System is CE-marked for use in patients recovering from stroke as a supplement to conventional rehabilitation. The navigation feature of NBT allows for accurately targeting therapy directly to the cortical structures believed to be involved in brain dysfunctions.
Next > Capricorn ICT Arkiv launched !
Previous > FRX Polymers Selected by AlwaysOn as a GoingGreen Silicon Valley Global 200 Winner